Report period | 2018 | 2019 | 2020 | 2021 | 2022 | Q3 23 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
DNB:US | Dun & Bradstreet | Common share | - | US26484T1060 | $9.36 |
Company name | Dun & Bradstreet Holdings |
---|---|
Sector | Financials / Diversified Financials / Diversified Financial Services / Other Diversified Financial Services |
Business address | 103 John F. Kennedy Parkway Short Hills, NJ 07078 United States |
Mailing address | 103 John F. Kennedy Parkway Short Hills, NJ 07078 United States |
Website | investor.dnb.com |
Information disclosure | www.sec.gov |